Mathieu Lamy

Mathieu Lamy is a seasoned Pharmaco-Epidemiologist currently employed at Sanofi since January 2023. Lamy has extensive experience as an Epidemiologist across various organizations, including AIXIAL and GSK, focusing on Phase IV epidemiology and clinical development studies related to malaria, particularly the RTS,S/AS01 vaccine. Lamy's prior roles include conducting infectious disease surveillance at InVS, evaluating nutrition programs for Médecins Sans Frontières in Burkina Faso, and implementing health-related studies in Myanmar. Academic qualifications include a Master's Degree in Epidemiology from ISPED and a Diplôme Universitaire in Project Management from CESH.